0001213900-23-098495.txt : 20231226
0001213900-23-098495.hdr.sgml : 20231226
20231226130925
ACCESSION NUMBER: 0001213900-23-098495
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231223
FILED AS OF DATE: 20231226
DATE AS OF CHANGE: 20231226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lemerond Nicole
CENTRAL INDEX KEY: 0001941712
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39685
FILM NUMBER: 231512411
MAIL ADDRESS:
STREET 1: 3 MURRAY HILL ROAD
CITY: SCARSDALE
STATE: NY
ZIP: 10583
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001728328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
BUSINESS PHONE: (604) 669-7207
MAIL ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
4
1
ownership.xml
X0508
4
2023-12-23
0
0001728328
InMed Pharmaceuticals Inc.
INM
0001941712
Lemerond Nicole
C/O INMED PHARMACEUTICALS INC.
310-815 WEST HASTINGS ST.
VANCOUVER
A1
V6C1B4
BRITISH COLUMBIA, CANADA
1
0
0
0
0
Employee Stock Option (Right to Buy)
0.37
2023-12-23
4
A
0
7100
0.00
A
2028-12-22
Common shares
7100
8500
D
The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner.
/s/ Eric Adams, attorney-in-fact for Ms. Nicole Lemerond
2023-12-26